At ASM Microbe 2026 in Washington, D.C., Bruker's Microbiology & Infection Diagnostics division is presenting an expanded portfolio across microbial identification, sepsis diagnostics, molecular testing, and next-generation sequencing. The breadth is real, but so is the spread in product readiness. For buyers, the useful exercise is sorting the showcase into what ships today, what is research use only, and what remains a development project.